Rare Genetic Disorder | $2.3 Million drug is needed to save 7-month old Baby Novah

Reading Time: 3 minutes

7-month-old, Baby Novah De Wet, from Aggeneys, Northern Cape, was diagnosed with Spinal Muscular Atrophy (SMA) type 1, a fatal, rare genetic disorder that affects important motor neurons in the body, responsible for movement and muscle development.

The condition which is the most common inherited fatal disease in infants can be treated with a miracle gene therapy drug, Zolgensma, available only in the US, which costs an astronomical R35 Million rand ($2.3 Million).

For a chance to receive the drug for at no cost, Baby Novah has entered the Global Managed Access programme offered by the drug manufacturer, Novartis, which has been established to offer free access to the once-off treatment to 100 patients worldwide per year in countries in which the drug is not yet approved, including South Africa.

With no guarantee that she will be selected as the one of the patients, as the program works with a ‘lottery’ system, the De Wet family have partnered with the Angel Network to launch a crowdfunding campaign on BackaBuddy, appealing to the public, and corporations for financial support during this difficult time.

“Hearing that our beautiful child has a life expectancy of just 2-years, is a sentence we just can’t accept, as we stare in our little girl’s eyes. Sleeping in my arms, we promised her we would fight for a happy ending, and that is exactly what we plan to do. While we have a steep mountain to climb, our mission is not impossible, and that is what we need to believe, to save our little supernova” – says  Clement.

Novartis has approved a three year payment plan for the drug, if the family can cover the cost of the R17.8 Million ($1.2 Million) deposit, which the campaign hopes to fund.

Since the launch of the campaign, generous donors have already made contributions to the value of R13 000. Funds raised will be paid directly to the relevant institution. Donors will be eligible for Section 18a tax certificates, issued by The Angel Network.

As baby Novah’s condition is extremely progressive, time is of the essence, says her dad, Clement.

“As a family, our dream is that our little girl can live a long, happy and healthy life. We know that with this drug, a bright future awaits our little one. We ask that you hear our hearts, share our story, and donate if you can. You will be saving baby Novah’s life, and heal our family” says  Clement.

Baby Novah with her dad, Clement, mom Charene and her big sister Hayleigh

If Baby Novah is selected in the lottery, funds raised will be returned to the donors or used to fund another patient with the same condition.

Support baby Novah by making a donation on BackaBuddy: https://www.backabuddy.co.za/baby-novah
Alternatively, make a donation via Snapscan: https://pos.snapscan.io/qr/baby-novah

Connect with Porky’s

Porky’s People NPC, is a non-profit organisation based in South Africa. We share inspiring South African stories, charitable causes and information worth spreading. 🌍 💜Our passion is people and non-profits.

Subscribe to our Newsletter – Find us on social media @porkyspeople.

Create a crowdfunding campaign

South Africa’s leading crowdfunding platform, BackaBuddy has supported more than 10 000+ individuals and charities in setting up fundraising campaigns for medical fees, tuition and various causes in South Africa. The platform has thus far raised over R310 Million.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.